A
Ablynx
Proprietary therapeutic proteins for treating life-threatening diseases
At a glance
- Status
- Listed
- Listing
- IPO 2007
News
Open roles
Ablynx in the Ghent ecosystem
The Ablynx office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- GIGimv
- GHGilde Healthcare
Sofinnova Partners
Series B and later8 investors entered at this stage
- FBFlanders Institute for Biotechnology
- APAlta Partners
- KBKBC
- KBKBC
- VBVrije Universiteit Brussel
- SOSR One
- AVAlta Ventures
- ABAbingworth
Source: Dealroom Talent Intelligence.
Alumni founders
Former Ablynx employees who went on to found companies, sorted by Dealroom signal score.
ARargenxEst. 2008
Tim Van HauwermeirenBelgium
CTConfo TherapeuticsEst. 2015
Jan SteyaertBelgium
OTOna TherapeuticsEst. 2019
CTCurve TherapeuticsEst. 2019
COComplixEst. 2008
Mark VaeckBelgiumPatents
3,641 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Ablynx on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


